US Patent 11046773 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
The present invention relates to bispecific polypeptides that are directed against the cellular receptor CD4 as well as a cellular co-receptor for HIV. Said polypeptides may be used to prevent human cell entry of HIV.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110467730
Date of Patent
June 29, 2021
0Patent Application Number
162950410
Date Filed
March 7, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110467730
Date of Patent
June 29, 2021
0Patent Application Number
162950410
Date Filed
March 7, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11046773 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
Infobox
Is a
Patent jurisdiction
Patent number
11046773
Date of patent
June 29, 2021
Patent application number
16295041
Date Filed
March 7, 2019
Patent primary examiner
Find more entities like US Patent 11046773 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
